BDX — BCAL Diagnostics Balance Sheet
0.000.00%
Last trade - 00:00- AU$27.65m
- AU$32.98m
- AU$2.55m
Annual balance sheet for BCAL Diagnostics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 9.57 | 3.17 | 6.47 | 4.52 | 1.59 |
| Net Total Receivables | 0.884 | 3.03 | 2.86 | 2.67 | 2.49 |
| Total Current Assets | 10.5 | 6.2 | 9.34 | 7.2 | 4.07 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.135 | 2.17 | 2.93 | 2.71 | 2.03 |
| Long Term Investments | |||||
| Total Assets | 10.6 | 8.37 | 12.3 | 9.91 | 7.66 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.95 | 2.26 | 2.6 | 3.11 | 3 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.95 | 3.16 | 3.68 | 3.69 | 8.49 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 9.64 | 5.21 | 8.59 | 6.22 | -0.826 |
| Total Liabilities & Shareholders' Equity | 10.6 | 8.37 | 12.3 | 9.91 | 7.66 |
| Total Common Shares Outstanding |